PHILADELPHIA, PA – March 31, 2025 – Carisma Therapeutics Inc. (Nasdaq: CARM) announced a revised operating plan to preserve resources and explore strategic alternatives, including potential asset sales, partnerships, or a company sale. The plan aims to maximize the...
Sanofi is making significant strides in the fight against chlamydia, the most common sexually transmitted bacterial infection, for which there are currently no approved preventative vaccines. The French pharmaceutical group has recently been granted a fast-track...
Turn Biotechnologies, a startup focused on mRNA therapies for cellular rejuvenation, has acquired an experimental drug delivery technology from Harvard University and Vesigen Therapeutics, according to an exclusive report by Endpoints News. The acquired technology,...
Verve Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to expand its ongoing clinical trial of VERVE-102, an experimental gene editing therapy aimed at lowering cholesterol and reducing the risk of heart disease, the company...
Introduction of a Universal Coronavirus Vaccine: A robust cross-immunity effect to combat virus mutations. SEOUL, South Korea, Jan. 8, 2025 /PRNewswire/ — The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The...
